AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
We have 2 of 19 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
The anti—OX40/IL-13 bispecific exhibited enhanced suppression of Th1, Th2, Th17, and Th22 inflammatory responses both in vitro and in vivo, indicating synergistic immunomodulation through dual target engagement.
A novel bispecific antibody that co-targets PD-1 and TL1A to achieve synergistic inhibition of pathogenic immune activation, with relevance to both PD-1 and TL1A driven immune disorders is developed, supporting its potential as a novel treatment for autoimmune diseases such as IBD.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.